Ultra Seal Pain Relief Recall: Stability Failure
Ultra Seal recalls Pain Relief Maximum Strength tablets due to failed stability specifications for salicylic acid. Check lot numbers AK8745, AK9751, and AK9552.
Recall notice
Failed Stability Specifications: Out-of-Specification (OOS) results for the Aspirin related compound Salicylic Acid was observed.
Contact the company
What happened, in plain English
Ultra Seal Corporation is recalling Pain Relief Maximum Strength tablets because they failed stability specifications regarding the aspirin-related compound salicylic acid. The recall covers approximately 4.6 million packets distributed to two distributors in Illinois and Texas. No remedy or specific health risks are detailed in the provided record. Read more at govinfonow.com/recall/36871-ultra-seal-pain-relief-recall-stability-failure.
Source Summary by GovInfoNow · govinfonow.com/recall/36871-ultra-seal-pain-relief-recall-stability-failure · Updated October 11, 2026 · FDA enforcement record: FDA #D-1512-2020
Cite this page
“Ultra Seal Pain Relief Recall: Stability Failure.” GovInfoNow, updated October 11, 2026. https://govinfonow.com/recall/36871-ultra-seal-pain-relief-recall-stability-failure. Based on FDA recall #D-1512-2020 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1512-2020%22&limit=1).
Why it’s dangerous
The record states that out-of-specification results were observed for salicylic acid, an aspirin-related compound, indicating a failure in stability specifications. The specific health consequences or mechanisms of injury resulting from this chemical deviation are not described in the provided text.
Who’s affected
Consumers who purchased Pain Relief Maximum Strength tablets manufactured by Ultra Seal Corporation between unspecified dates and with expiration dates of August 2020, August 2021, or April 2022. Individuals in Illinois and Texas are more likely to have received the product through local distributors.
How to tell if you have this one
Look for Pain Relief Maximum Strength tablets (Acetaminophen 250 mg/aspirin 250 mg/Caffeine 65 mg) in 2-tablet packets. Check the lot numbers AK8745, AK9751, or AK9552 and expiration dates of 08/20, 08/2021, or 04/2022.
- Brand
Ultra Seal- Category
Drug
All 2 products in this recall
FDA lists each product line separately under one recall event. Check your product description, lot or code numbers against each row. Every row shares the hazard and remedy on this page.
- Classification
Class III- Status
Terminated- Distribution
Product was shipped to two distributors in IL and TX who may have further repackaged and distributed the product.
| Recall number | Product, codes & lots | Quantity |
|---|---|---|
| D-1512-2020 | Pain Relief Maximum Strength (Acetaminophen 250 mg/aspirin 250 mg/Caffeine 65 mg) tablets, 2-tablets per packet, Manufactured for Select Corporation, Carrollton, TX 75007; Lot #: AK8745, Exp. Date 08/20; AK9751, Exp. Date 08/2021; AK9552, Exp. Date 04/2022 | 4,666,355 packets |
| D-1513-2020 | Extra Strength Headache Relief (Acetaminophen 250 mg/aspirin 250 mg/Caffeine 65 mg) tablets, 2-tablet packets, Manufactured for: Convenience Valet Glendale Heights, IL 60139,; Lot #: K-8909, AK8909, Exp. Date 12/2020; AK9507, Exp. Date 03/2021; AK9072, Exp. Date 04/2021; AK9102, AK9601, AK9679, Exp. Date 05/2021; AK9145, K9145, Exp. Date 06/2021; AK9743, AK9830, Exp. Date 07/2021; AK9276, Exp. Date 09/2021; AK9391, A9392, Exp. Date 12/2021; AK9505, Exp. Date 02/2022; AK9508, AK9509 Exp. Date 04/2022 | 701,735 packets |
Where it went and when
Where it was distributed
Distributed in Illinois and Texas.
FDA distribution: “Product was shipped to two distributors in IL and TX who may have further repackaged and distributed the product.” States read from FDA’s own wording; “not listed” means the notice does not name it.
States: Illinois, Texas.
Recall timeline
FDA terminated this recall 7 months after the firm started it.
- Firm started the recall
- FDA classified it Class III
- Published in FDA’s Enforcement Report
- FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
Similar recalls
Latest drug recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-1512-2020 (August 3, 2020) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-1512-2020 to see it in context.
- Plain-language summary written by qwen3.6:35b-a3b on October 11, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.